Modified Asthma Predictive Index (mAPI)
Predicts future asthma in pediatric patients.
This score applies to pediatric patients ≤3 years old.
Advice
Unfortunately, while the mAPI was used successfully to identify high asthma risk children in a randomized trial, there was no long term benefit found from inhaled corticosteroids on the development of asthma or lung function.